Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Aspen Pharmacare (APNHY : OTC)

• Company Description    Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa. Number of Employees: 9,350

• Price / Volume Information    Yesterday's Closing Price: $6.99 Daily Weekly Monthly 20 Day Moving Average: 248 shares Shares Outstanding: (millions) Market Capitalization: $ (millions) Beta: 0.96 52 Week High: $13.69 52 Week Low: $5.76 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 1.81% -2.72% 12 Week -9.32% -22.55% Year To Date -15.36% -20.72%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 9 Rydall Vale Park Douglas Saunders Drive La Lucia Ridge - Durban,T3 4051 ZAF ph: 27-31-580-8600 fax: 27-11-239-6144 None http://www.aspenpharma.com

• General Corporate Information    Officers Stephen Saad - Chief Executive Officer Kuseni Dlamini - Chairman Sean Capazorio - Chief Financial Officer Linda de Beer - Director Yvonne Muthien - Director Peer Information Aspen Pharmacare (BGMR) Aspen Pharmacare (BBIO) Aspen Pharmacare (IPAH) Aspen Pharmacare (BRL) Aspen Pharmacare (BHC) Aspen Pharmacare (AKRXQ) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-GENERIC DRG Sector: Medical CUSIP: 04530Y106 SIC: 8880 Fiscal Year Fiscal Year End: June Last Reported Quarter: - Next Expected EPS Date: 09/02/25 Share - Related Items Shares Outstanding: Most Recent Split Date: (:1) Beta: 0.96 Market Capitalization: $ (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 1.78% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.12 Current Fiscal Year EPS Consensus Estimate: $0.70 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 09/02/25

• Fundamental Ratios P/E Current FY Estimate: 9.99 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.68 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - - 03/31/25 - - 12/31/24 - - Current Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - 2.35 Quick Ratio 06/30/25 - - 03/31/25 - - 12/31/24 - 1.25 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - - 12/31/24 - - Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - 0.36 Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - 26.64

Powered by Zacks Investment Research ©